Related Experiment Videos
Autoimmune hemolytic anemia associated with anti-Sc1
I Owen1, V Chowdhury, M E Reid
1Department of Haematology, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
Transfusion
|February 1, 1992
Summary
A rare case of autoimmune hemolytic anemia (AIHA) in a child resistant to steroids was successfully treated with splenectomy and immunoglobulin. The autoantibody identified was anti-Sc1, a novel finding in pediatric AIHA.
Area of Science:
- Pediatric Hematology
- Immunology
- Serology
Background:
- Autoimmune hemolytic anemia (AIHA) is a rare condition characterized by antibody-mediated red blood cell destruction.
- Steroid therapy is a common first-line treatment for AIHA, but treatment resistance can occur.
Observation:
- A pediatric case of AIHA presented with hemolysis resistant to standard steroid treatment.
- The patient's condition improved following splenectomy and administration of intravenous immunoglobulin.
Findings:
- Serologic and immunoblotting techniques identified the autoantibody as anti-Sc1.
- This is the first reported instance of anti-Sc1 autoantibody detected by immunoblotting in AIHA.
- This case represents the first documented pediatric AIHA caused by an anti-Sc1 autoantibody.
Implications:
- The findings expand the known autoantibody profiles associated with pediatric AIHA.
- Immunoblotting is a valuable tool for characterizing autoantibodies in refractory AIHA cases.
- Splenectomy and intravenous immunoglobulin are potential therapeutic options for steroid-resistant pediatric AIHA.